Table 5.
The indexes of technology performance
| technology performance index Author | Suspicion index | Improving of CNR, image resolution and image contrast | SN | SP | oxygenation index | Physical changes in the breast | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leff et al. [4]*1 | - | - | - | 96% | 93% | - | - | ||||||
| Parisky et al. [6] | 875 biopsied lesions | 479 biopsied lesions and 110 malignancies | - | - | - | - | - | ||||||
| SN | SP | PPV | NPV | SN | SP | PPV | NPV | ||||||
| 97% | 14% | 24% | 95% | 99% | 18% | 27% | 99% | ||||||
| Li et al. [7] | - | P-value<0/05 (by using spatial information) | - | - | - | - | |||||||
| Heffer et al. [8] | - | - | - | - | P-value<0/05 (by 4 combined wavelengths 690, 750, 788, and 856 nm) | - | |||||||
| Cerussi et al [9] | P-value<0/05 (by multi spectral measurement) | - | |||||||||||
| Taroni et al. [10] | - | P-value<0/05 (by wavelengths shorter than 680-780 nm) | - | - | - | - | |||||||
| van Veen et al. [11] | - | P-value<0/05 (by wavelength 640nm) | - | - | - | - | |||||||
| Busch et al [12]*2 | - | - | DOT CAD | DOT CAD | - | - | |||||||
| 89% | 94% | ||||||||||||
| Simick et al. [13] | - | - | - | - | - | P-value<0/05 | |||||||
| Turgut et al. [14] | - | - | - | - | - | P-value<0/05 | |||||||
| Pifferi et al. [15] | - | - | - | - | - | P-value<0/05 (by 3 combined wavelengths 683, 912, 975 nm) | - | ||||||
| Grosenick et al. [16] | - | - | - | - | - | P-value<0/05 (decreased in breast tumors) | P-value<0/05 | ||||||
SN: sensitivity
PPV: positive predictive value
*(1): standard for comparison: X- ray mammography
CNR: contrast to noise ratio
DOT CAD: Diffuse Optical Tomography Computer Aided Detection
SP: specificity
NPV: negative predictive value
*(2): standard for comparison: tissue segmentations